CRO Services Center (Phase I-III)

Clinical Trials are required for drug therapies to receive regulatory approval.

A Phase 1 trial is the first to involve human subjects, and their objective is to determine the highest does of a treatment that can be safely administered to patients. A Phase 2 trial is conducted on a small number of patients to determine if the drug is effective. If the Phase 1 and Phase 2 trials are successful, a larger Phase 3 trial is conducted to gather data to present to the FDA. In a Phase 3 trial a drug is often tested against a placebo or the current standard of care. Clinical trials are expensive and time consuming, and they require expertise in many areas. Sponsors need to perform study startup (which includes site selection and patient recruitment), manage and oversee the trial, and collect and analyze trial data. All of these operations can be performed by a CRO.

How can we help?

Looking for help with your Phase I-III project? If you're searching for information or a supplier, let Clinical Leader lend you a hand.

Submit A Question

CRO Services Center (Phase I-III) Provider - Catalyst Clinical Research
Catalyst Clinical Research

Catalyst Clinical Research is a clinical development organization providing highly customizable solutions to the global biopharmaceutical industry. Built from more than two decades of listening to their customers, devising customer-centric solutions and helping them breakthrough with clinical development programs surrounded by therapeutically aligned teams of experts.

Capabilities

Ciox Real World Data
Ciox Real World Data

Utilizing its DataFit Platform™, the Ciox Real World Data division (Ciox RWD) securely and consistently curates disparate data sets to enable researchers to access valuable clinical information that may otherwise be hidden in or across different parts of workflow systems that house medical records. The Ciox DataFit Platform™ utilizes clinical rules-based medical concept translation with unstructured data sets to build highly structured clinical data that can be used by researchers to advance care for patients.

Capabilities

CRO Services Center (Phase I-III) Provider - Cmed Clinical Research Services
Cmed Clinical Research Services

Where Technology Meets Expertise. No other CRO is better prepared to support the future of clinical trials. Technology-led, user-focused and with expertise in oncology, cell & gene therapy, rare diseases, data science and analytics, we pioneered next generation trials. As the industry continues to undergo seismic change, our 20 years of expertise enables us to embrace radical disruption and transform the clinical trials landscape for the benefit of patients.

Capabilities


Have questions about selecting the right Phase I-III service provider?

The Clinical Leader team can help. We'll match your needs with the right companies.

Contact us via email for assistance.


CRO Services Center (Phase I-III) Provider - Cytel
Cytel

Now more than ever, the clinical development path is full of make-or-break data complexities and analytical challenges. As a pioneer in evidence generation, with deep expertise in advanced analytical solutions, we are uniquely equipped to unlock the value from increasingly complex data. Life Sciences companies count on Cytel to deliver exceptional insight, minimize trial risk and accelerate the development of promising new medicines that improve human life.

Capabilities

CRO Services Center (Phase I-III) Provider - inSeption Group
inSeption Group

inSeption distinguishes people as the most impactful variable in the outsourcing equation. Our path-breaking model attracts biopharma companies who demand a partner that shares in their drive to conduct impeccable development and will provide quality and dependable clinical solutions. We offer full outsourcing, consulting services, and functional service provider (FSP) solutions.

Capabilities

CRO Services Center (Phase I-III) Provider - IQVIA Biotech
IQVIA Biotech

IQVIA Biotech delivers flexible clinical development solutions designed to help biotech and emerging biopharma companies get treatments to patients. When you partner with our clinical team, you gain expertise from two decades of running clinical trials exclusively for biotech companies. We understand the unique challenges, hurdles, and opportunities you face. From strategy and trial design to execution, we draw on this experience to put together the right solution for you.

Capabilities


CRO Services Center (Phase I-III) Provider - PAREXEL
Parexel

Parexel is in the business of improving the world's health. We do this by providing a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments. From clinical trials to regulatory, consulting, and market access, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do.

CRO Services Center (Phase I-III) Provider - Premier Research
Premier Research

Premier Research recognizes that when an emerging biotech is built around a single asset, focus and flexibility are critical to success. And, since many of our customers require additional infrastructure, we fill in resourcing gaps to help their product reach the patient faster. We are a mid-size CRO and offer strategies that are customized for each program, with tailored processes designed to meet highly specific needs.

Capabilities

CRO Services Center (Phase I-III) Provider - Rho
Rho

Rho, a privately held CRO located in RTP, NC, provides clinical research services across the entire drug development process. Since 1984, Rho has been a trusted partner to the industry's leading pharmaceutical, biotechnology, medical device companies, and academic and government organizations. Our commitment to excellence, innovative technologies, and therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience.


CRO Services Center (Phase I-III) Provider - United BioSource - UBC
United BioSource - UBC

United BioSource LLC (UBC) is a leading provider of pharmaceutical support services, partnering with life science companies to make medicine and medical products safer and more accessible. UBC is well known for our expertise in generating authoritative, real-world evidence of product effectiveness, safety, and value to assist healthcare decisions and enhance patient care.

Capabilities

CRO Services Center (Phase I-III) Provider - Worldeide Clinical Trials
Worldwide Clinical Trials

Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, general medicine, oncology and rare diseases. We never compromise on science or safety. We're never satisfied with the status quo. We're the Cure for the Common CRO.

Capabilities